Zain Rizvi, M.D.
Dr. Rizvi is a board certified Otolaryngologist-Head and Neck surgeon and assistant professor. He grew up on the West Coast and Midwest and graduated medical school with high honors, distinction in research, and Alpha Omega Alpha Honor society induction. He completed residency training at the University of California in Los Angeles. Driven to provide comprehensive head & neck and reconstructive care, he then pursued training at Washington University in St. Louis and Barnes-Jewish Hospital. There he completed training in advanced head and neck oncology, reconstructive, endoscopic/open skull base, transoral laser and robotic as well as endocrine surgery.
His clinical practice is comprehensive head & neck and reconstructive care. His focus is to maximize and restore form, function, and quality of life through innovative techniques. This often includes minimally invasive robotic, laser, and endoscopic techniques as well as reconstructive surgery, including free tissue transfer. To achieve this, he works with multidisciplinary teams across specialties to develop the best treatment options for each individual patient.
In his spare time, he enjoys the outdoors – hiking, biking, fishing, making the Pacific Northwest a great home. He also enjoys car repair and restoration as well as cooking.
Undergraduate Education: University of Michigan, 2007
Medical School: Wayne State University School of Medicine, 2013
Internship: University of California Los Angeles, General Surgery, 2014
Residency: University of California Los Angeles, Otolaryngology – Head and Neck Surgery, 2018
Fellowship: Washington University in St. Louis/Barnes Jewish Hospital, Comprehensive Head & Neck Oncology, Microvascular Reconstruction, Transoral Robotic & Laser, Endoscopic & Open Skull Base, and Endocrine Surgery, 2019
Other Training: Howard Hughes Medical Institute/University of Texas MD Anderson Cancer Center, Medical Research Fellowship, 2010
Board Certification: Otolaryngology-Head and Neck Surgery, 2019
Memberships: American Head and Neck Society, American Academy of Otolaryngology, Alpha Omega Alpha Honor Society
Awards and honors
2018 Paul Ward Society 1st place Award for Outstanding Research
2017 Ballantyne Resident Research Pilot CORE Grant, AHNS
2013 Elected to Alpha Omega Alpha Society
2013 Comprehensive Honors in Medical School (Top 5%)
2012 Award for Highest Academic Achievement amongst Third Year Medical Students
2009-10 Howard Hughes Medical Institute Medical Student Research Training Fellowship
2008 Wayne State University Board of Governors Scholarship
2007 Detroit Section American Chemical Society (ACS) Distinguished Student Award
2007 American Chemical Society (ACS) Award in Biochemistry
2005 American Chemical Society (ACS) Award for Analytical Chemistry
2004 University of Michigan Angel Scholar
2003 University of Michigan Competitive Scholarship, Minority Recognition Scholarship, Dean’s List for Achievement
Head and Neck oncology, functional reconstruction following tumor removal or trauma, endoscopic and open skull base surgery for treatment of sinonasal tumors and disease, transoral robotic (TORS) and laser microsurgery (TLM), endocrine surgery (thyroid, parathyroid, and pituitary).
Dr. Rizvi’s research focus is on improving quality of life and treatment in patients undergoing head and neck treatment. This includes studies to guide decision making in order to maximize patient-centered outcomes as well as translational research to advance our fundamental understanding of disease, hopefully leading to new potential treatment options.
Gibson AW, Gobillot TA, Bass DI, Zakarevicius Z, Rizvi ZH, Ravanpay AC. Case of Esophageal Perforation and Repair with a Supraclavicular Artery Island Fascial Flap 15 Years After Anterior Spine Surgery., World Neurosurg 2020 11; 143102-107
Gross JH, Vila PM, Simon L, Rizvi ZH, Zenga J, Jackson RS, Pipkorn P. Elective neck dissection during salvage laryngectomy: A systematic review and meta-analysis., Laryngoscope 2020 04; 130(4):899-906
Rizvi ZH, Ferrandino R, Luu Q, Suh JD, Wang MB. Nationwide analysis of unplanned 30-day readmissions after transsphenoidal pituitary surgery., Int Forum Allergy Rhinol 2019 03; 9(3):322-329
Rizvi ZH, Alonso JE, Kuan EC, St John MA. Treatment outcomes of patients with primary squamous cell carcinoma of the retromolar trigone., Laryngoscope 2018 12; 128(12):2740-2744